Vaxart, Inc.
VXRT
$0.58
$0.022.70%
OTC PK
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -62.37% | 43.95% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -62.37% | 43.95% | |||
| Cost of Revenue | -34.85% | -40.55% | |||
| Gross Profit | -83.39% | 1,772.01% | |||
| SG&A Expenses | 26.60% | -14.29% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -30.24% | -39.15% | |||
| Operating Income | -90.67% | 809.55% | |||
| Income Before Tax | -90.60% | 781.79% | |||
| Income Tax Expenses | -91.57% | 1,923.53% | |||
| Earnings from Continuing Operations | -90.59% | 776.15% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -90.59% | 776.15% | |||
| EBIT | -90.67% | 809.55% | |||
| EBITDA | -89.04% | 1,102.93% | |||
| EPS Basic | -90.79% | 755.62% | |||
| Normalized Basic EPS | -90.80% | 761.26% | |||
| EPS Diluted | -91.39% | 752.25% | |||
| Normalized Diluted EPS | -90.86% | 760.36% | |||
| Average Basic Shares Outstanding | 2.03% | 3.03% | |||
| Average Diluted Shares Outstanding | 2.55% | 3.16% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||